Obinutuzumab for the First-Line Treatment of Follicular Lymphoma von Marcus, Robert, Davies, Andrew, Ando, Kiyoshi, Klapper, Wolfram, Opat, Stephen, Owen, Carolyn, Phillips, Elizabeth, Sangha, Randeep, Schlag, Rudolf, Seymour, John F, Townsend, William, Trněný, Marek, Wenger, Michael, Fingerle-Rowson, Günter, Rufibach, Kaspar, Moore, Tom, Herold, Michael, Hiddemann, Wolfgang

Volltext

Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label,... von Sehn, Laurie H, Dr, Chua, Neil, MD, Mayer, Jiri, Prof, Dueck, Gregg, MD, Trněný, Marek, Prof, Bouabdallah, Kamal, MD, Fowler, Nathan, MD, Delwail, Vincent, MD, Press, Oliver, Prof, Salles, Gilles, MD, Gribben, John, Prof, Lennard, Anne, MBBS, Lugtenburg, Pieternella J, MD, Dimier, Natalie, MSc, Wassner-Fritsch, Elisabeth, PharmD, Fingerle-Rowson, Günter, MD, Cheson, Bruce D, Prof

Volltext

Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma von Vitolo, Umberto, Trněný, Marek, Belada, David, Burke, John M, Carella, Angelo Michele, Chua, Neil, Abrisqueta, Pau, Demeter, Judit, Flinn, Ian, Hong, Xiaonan, Kim, Won Seog, Pinto, Antonio, Shi, Yuan-Kai, Tatsumi, Yoichi, Oestergaard, Mikkel Z, Wenger, Michael, Fingerle-Rowson, Günter, Catalani, Olivier, Nielsen, Tina, Martelli, Maurizio, Sehn, Laurie H

Volltext

Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study von Ramchandren, Radhakrishnan, Domingo-Domènech, Eva, Rueda, Antonio, Trněný, Marek, Feldman, Tatyana A, Lee, Hun Ju, Provencio, Mariano, Sillaber, Christian, Cohen, Jonathon B, Savage, Kerry J, Willenbacher, Wolfgang, Ligon, Azra H, Ouyang, Jing, Redd, Robert, Rodig, Scott J, Shipp, Margaret A, Sacchi, Mariana, Sumbul, Anne, Armand, Philippe, Ansell, Stephen M

Volltext

Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial von Trněný, Marek, Prof, Lamy, Thierry, Prof, Walewski, Jan, Prof, Belada, David, MD, Mayer, Jiri, MD, Radford, John, Prof, Jurczak, Wojciech, MD, Morschhauser, Franck, Prof, Alexeeva, Julia, MD, Rule, Simon, Prof, Afanasyev, Boris, Prof, Kaplanov, Kamil, MD, Thyss, Antoine, Prof, Kuzmin, Alexej, MD, Voloshin, Sergey, MD, Kuliczkowski, Kazimierz, Prof, Giza, Agnieszka, MD, Milpied, Noel, Prof, Stelitano, Caterina, MD, Marks, Reinhard, MD, Trümper, Lorenz, Prof, Biyukov, Tsvetan, MD, Patturajan, Meera, PhD, Bravo, Marie-Laure Casadebaig, MSc, Arcaini, Luca, Prof

Volltext

A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA von Sehn, Laurie H, Martelli, Maurizio, Trněný, Marek, Liu, Wenxin, Bolen, Christopher R, Knapp, Andrea, Sahin, Deniz, Sellam, Gila, Vitolo, Umberto

Volltext

Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis von Muraro, Paolo A, Pasquini, Marcelo, Atkins, Harold L, Bowen, James D, Farge, Dominique, Fassas, Athanasios, Freedman, Mark S, Georges, George E, Gualandi, Francesca, Hamerschlak, Nelson, Havrdova, Eva, Kimiskidis, Vassilios K, Kozak, Tomas, Mancardi, Giovanni L, Massacesi, Luca, Moraes, Daniela A, Nash, Richard A, Pavletic, Steven, Ouyang, Jian, Rovira, Montserrat, Saiz, Albert, Simoes, Belinda, Trnený, Marek, Zhu, Lin, Badoglio, Manuela, Zhong, Xiaobo, Sormani, Maria Pia, Saccardi, Riccardo

Volltext

Zanubrutinib monotherapy for patients with treatment naïve chronic lymphocytic leukemia and 17p deletion von Tam, Constantine S, Robak, Tadeusz, Ghia, Paolo, Kahl, Brad S, Walker, Patricia, Janowski, Wojciech, Simpson, David, Shadman, Mazyar, Ganly, Peter S, Laurenti, Luca, Opat, Stephen, Tani, Monica, Ciepluch, Hanna, Verner, Emma, Šimkovič, Martin, Österborg, Anders, Trněný, Marek, Tedeschi, Alessandra, Paik, Jason C, Kuwahara, Sowmya B, Feng, Shibao, Ramakrishnan, Vanitha, Cohen, Aileen, Huang, Jane, Hillmen, Peter, Brown, Jennifer R

Volltext

To the ring-shaped nucleolus seen by microscopy using human lymphocytes of blood donors and chronic lymphocytic leukemia patients von Smetana, Karel, Mikulenková, Dana, Karban, Josef, Trněný, Marek

Volltext

A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffus... von Czuczman, Myron S, Trněný, Marek, Davies, Andrew, Rule, Simon, Linton, Kim M, Wagner-Johnston, Nina, Gascoyne, Randy D, Slack, Graham W, Brousset, Pierre, Eberhard, David A, Hernandez-Ilizaliturri, Francisco J, Salles, Gilles, Witzig, Thomas E, Zinzani, Pier Luigi, Wright, George W, Staudt, Louis M, Yang, Yandan, Williams, P Mickey, Lih, Chih-Jian, Russo, Jacqueline, Thakurta, Anjan, Hagner, Patrick, Fustier, Pierre, Song, Dale, Lewis, Ian D

Volltext

R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes von Seymour, John F, Pfreundschuh, Michael, Trnĕný, Marek, Sehn, Laurie H, Catalano, John, Csinady, Eva, Moore, Nicola, Coiffier, Bertrand

Volltext

Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study von Kostakoglu, Lale, Mattiello, Federico, Martelli, Maurizio, Sehn, Laurie H, Belada, David, Ghiggi, Chiara, Chua, Neil, González-Barca, Eva, Hong, Xiaonan, Pinto, Antonio, Shi, Yuankai, Tatsumi, Yoichi, Bolen, Christopher, Knapp, Andrea, Sellam, Gila, Nielsen, Tina, Sahin, Deniz, Vitolo, Umberto, Trněný, Marek

Volltext

Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial von Tam, Constantine S, Brown, Jennifer R, Kahl, Brad S, Ghia, Paolo, Giannopoulos, Krzysztof, Jurczak, Wojciech, Šimkovič, Martin, Shadman, Mazyar, Österborg, Anders, Laurenti, Luca, Walker, Patricia, Opat, Stephen, Chan, Henry, Ciepluch, Hanna, Greil, Richard, Tani, Monica, Trněný, Marek, Brander, Danielle M, Flinn, Ian W, Grosicki, Sebastian, Verner, Emma, Tedeschi, Alessandra, Li, Jianyong, Tian, Tian, Zhou, Lei, Marimpietri, Carol, Paik, Jason C, Cohen, Aileen, Huang, Jane, Robak, Tadeusz, Hillmen, Peter

Volltext

A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma von Morschhauser, Franck, Feugier, Pierre, Flinn, Ian W., Gasiorowski, Robin, Greil, Richard, Illés, Árpád, Johnson, Nathalie A., Larouche, Jean-François, Lugtenburg, Pieternella J., Patti, Caterina, Salles, Gilles A., Trněný, Marek, de Vos, Sven, Mir, Farheen, Samineni, Divya, Kim, Su Y., Jiang, Yanwen, Punnoose, Elizabeth, Sinha, Arijit, Clark, Emma, Spielewoy, Nathalie, Humphrey, Kathryn, Bazeos, Alexandra, Zelenetz, Andrew D.

Volltext

Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia von Kuter, David J, Efraim, Merlin, Mayer, Jiri, Trněný, Marek, McDonald, Vickie, Bird, Robert, Regenbogen, Thomas, Garg, Mamta, Kaplan, Zane, Tzvetkov, Nikolay, Choi, Philip Y, Jansen, A.J. Gerard, Kostal, Milan, Baker, Ross, Gumulec, Jaromir, Lee, Eun-Ju, Cunningham, Ilona, Goncalves, Isaac, Warner, Margaret, Boccia, Ralph, Gernsheimer, Terry, Ghanima, Waleed, Bandman, Olga, Burns, Regan, Neale, Ann, Thomas, Dolca, Arora, Puneet, Zheng, Beiyao, Cooper, Nichola

Volltext

Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in t... von Cheson, Bruce D, Chua, Neil, Mayer, Jiri, Dueck, Greg, Trněný, Marek, Bouabdallah, Kamal, Fowler, Nathan, Delwail, Vincent, Press, Oliver, Salles, Gilles, Gribben, John G, Lennard, Anne, Lugtenburg, Pieternella J, Fingerle-Rowson, Günter, Mattiello, Federico, Knapp, Andrea, Sehn, Laurie H

Volltext

Retrospective Analysis of 118 Patients With Cutaneous T-Cell Lymphomas: A Single-Center Experience von Polgárová, Kamila, Polívka, Jindřich, Kodet, Ondřej, Klener, Pavel, Trněný, Marek

Volltext

The Reduction of the Cell Nuclear Size in the Cell Body Space During the Differentiation Might Be Cell Lineage Specific (A Retrospective Morphological Note) von Smetana, K, Klamová, H, Mikulenková, D, Karban, J, Trněný, M

Volltext

ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma von Zinzani, Pier Luigi, Mayer, Jiří, Flowers, Christopher R, Bijou, Fontanet, De Oliveira, Ana C, Song, Yuqin, Zhang, Qingyuan, Merli, Michele, Bouabdallah, Krimo, Ganly, Peter, Zhang, Huilai, Johnson, Roderick, Martín García-Sancho, Alejandro, Provencio Pulla, Mariano, Trněný, Marek, Yuen, Sam, Tilly, Herve, Kingsley, Edwin, Tumyan, Gayane, Assouline, Sarit E, Auer, Rebecca, Ivanova, Elena, Kim, Pil, Huang, Sha, Delarue, Richard, Trotman, Judith

Volltext

Lenalidomide enhances antitumor functions of chimeric antigen receptor modified T cells von Otáhal, Pavel, Průková, Dana, Král, Vlastimil, Fabry, Milan, Vočková, Petra, Latečková, Lucie, Trněný, Marek, Klener, Pavel

Volltext